Personalized vaccine helped melanoma patients stay cancer-free longer, drugmakers say
An experimental vaccine kept melanoma from returning or spreading in people at high risk of the skin cancer recurring, drugmakers Moderna and Merck announced Wednesday.
Aug 23, 2026
0
10
